Coagulation state of critically ill patients with acute renal failure undergoing continuous veno-venous citrate-dialysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004336

Enrollment

Registered

2012-08-29

Start date

2013-08-26

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coagulation state in patients with acute renal failure undergoing citratedialysis D68.9

Interventions

Group 1: critically ill patients undergoing citratdialysis receiving enoxaparin 40mg/d for prophylaxis of Venous thromboembolism blood samples for ROTEM,TG and Multiplate(twice a day), antiXa (four ti

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Acute renal failure indicating CRRT and VTE prophylaxis with enoxaparin 40mg/d s.c.

Exclusion criteria

Exclusion criteria: 1.Age < 18 years 2.Contraindication for thromboembolic prophylaxis with heparins

Design outcomes

Primary

Measure	Time frame
to find out about correlation between ROTEM® / TG / Multiplate and defined clinical endpoints (venous thromboembolism, mortality) ROTEM and TG will be done twice a day for 3 days	—

Secondary

Measure	Time frame
observation of the time course of anti Xa, ROTEM®, TG and Multiplate in critically ill patients receiving standard pharmacological prophylaxis and undergoing citrate-dialysis ROTEM and TG will be done twice a day and antiXa four times a day over a period of three days	—

Countries

Austria

Contacts

Public ContactMarion Wiegele

AKH Wien Abteilung für Anästhesie, Intensivmedizin und Schmerztherapie

marion.wiegele@meduniwien.ac.at0043/1/40400

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 15, 2026